Expert Highlights Avelumab Trial and Future of Immunotherapy in Head and Neck Cancer - OncLive

OncLive

Expert Highlights Avelumab Trial and Future of Immunotherapy in Head and Neck Cancer OncLive Eligible patients have stage III to IVb locally-advanced squamous cell carcinoma of the oral cavity, oropharynx, larynx, or hypopharynx, and are HPV-negative or nonoropharyngeal HPV-positive. Patients who have HPV-positive oropharyngeal disease that is ... and more »

from # All Medicine by Alexandros G. Sfakianakis via Alexandros G.Sfakianakis on Inoreader http://ift.tt/2vL2Mkh
via IFTTT